期刊文献+

子宫内膜间质肉瘤97例临床分析 被引量:7

Clinical review of 97 patients with endometriul stromal sarcoma
原文传递
导出
摘要 目的探讨子宫内膜间质肉瘤(ESS)患者的预后及其相关因素,并分析术后辅助治疗对其复发及生存的影响。方法回顾性分析1970年1月—2006年5月在中国医学科学院中国协和医科大学肿瘤医院收治的97例ESS患者的临床资料。其中,低度恶性子宫内膜间质肉瘤(LGESS)69例,高度恶性子宫内膜间质肉瘤(HGESS)16例,不详者12例。患者中位年龄44.0岁,中位随访时间62个月(5~277个月);主要症状为阴道不规则流血(占43%)和经量增多、经期延长(占36%)。结果患者总的2年、5年累积生存率分别为93%和84%,LGESS与HGESS、Ⅰ~Ⅱ期与Ⅲ~Ⅳ期患者间的累积生存率比较,差异均有统计学意义(P〈0.05);术后放疗与未放疗、化疗与未化疗患者间的累积生存率比较,差异均无统计学意义(P〉0.05)。97例ESS患者中共有34例(37%)患者出现复发转移,中位复发转移时间为27个月(3—150个月)。其中LGESS与HGESS复发转移率分别是25%和73%,两者比较,差异有统计学意义(P=0.007);初次治疗保留卵巢功能和未保留卵巢功能者的复发转移率分别为89%和24%,两者比较,差异有统计学意义(P=0.000);术后化疗与未化疗者的复发转移率分别为35%和37%,两者比较,差异无统计学意义(P〉0.05)。术后放疗与未放疗者的局部控制率分别为81%和43%,两者比较,差异有统计学意义(P=0.011)。结论HGESS的预后明显不如LGESS,初治时保留卵巢功能者复发转移的风险明显高于未保留卵巢功能者,术后放疗可提高ESS患者的局部控制率。 Objective To review the survival outcomes in patients with endometrial stromal sarcoma (ESS) in Cancer Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, and to discuss prognostic factors and the role of post-operative adjuvant radiotherapy and chemotherapy. Methods Hospital records and pathology reports for 97 patients with ESS were reviewed. Among 97 patients, 69 had low-grade ESS ( LGESS), 16 had high-grade ESS (HGESS) and 12 had unclear grade. The median age at diagnosis was 44. 0 years. The median follow-up time was 62 months ( 5 - 277 months). Atypical vaginal bleeding (43%) and prolonged and increased menses (36%) were the main symptoms. Results Totally 2-year and 5-year cumulative survival rates were 93% and 84%, respectively. Cumulative survival curves were significantly different between LGESS and HGESS, and so did cumulative survival curves between stage Ⅰ - Ⅱ and stage Ⅲ- Ⅳ(P〈0.05). Totally, 34 patients (37%) had local or distant recurrence. The median time-to-recurrence (TTR) was 27 months. The recurrence rates of the patients with or without preserve of ovary were 89% and 24% , respectively ( P =0. 000). The local-control-rates of the patients who received or did not receive post-operative radiotherapy were 81% and 43%, respectively (P = 0. 011 ). Conclusions The prognosis of HGESS is obviously worse than that of LGESS. The risk of recurrence of patients with preserve of ovary was remarkably higher than that of patients without preserve of ovary. Postoperative radiotherapy could increase the local-control-rates.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2008年第2期115-119,共5页 Chinese Journal of Obstetrics and Gynecology
关键词 子宫内膜肿瘤 肉瘤 子宫内膜间质 肿瘤复发 局部 预后 Endometrial neoplasms Sarcoma, endometrial stromal Neoplasm recurrence, local Prognosis
  • 相关文献

参考文献15

  • 1Diesing D, Cordes T, Finas D, et al. Endometrial stromal sarcomas : a retrospective analysis of 11 patients. Anticancer Res,2006, 26:655-661.
  • 2Gadducci A, Sartori E, Landoni F, et al. Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol, 1996, 63:247-253.
  • 3Amant F, Vergote I, Moennan P. The classification of a uterine sarcoma as high-grede endometrial stromal sarcoma' should be abandoned. Gynecol Oncol, 2004, 95:412-413.
  • 4张欣,吴令英,李晓江,李洪君,张蓉,刘丽影.盆腔良性肿物伴血清CA_(125)水平升高的临床意义[J].中华妇产科杂志,2005,40(3):178-182. 被引量:65
  • 5Weitmann HD, Knocke TH, Kucera H, et al. Radiation therapy in the treatment of endometrial stromal sarcoma. Int J Radiat Oncol Biol Phys, 2001,49:739-748.
  • 6Berchuck A, Rubin SC, Hoskins WJ, et al. Treatment of endometrial stromal tumors. Gynecol Oncol, 1990, 36:60-65.
  • 7Reich O, Regauer S. Survey of adjuvant hormone therapy in patients after endometrial stromal sarcoma. Eur J Gynaecol Oncol, 2006, 27 : 150-152.
  • 8Riopel J, Plante M, Renaud MC, et al. Lymph node metastases in low-grade endometrial stromal sarcoma. Gynecol Oncol, 2005, 96:402-406.
  • 9Geller MA, Argenta P, Bradley W, et al. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression. Gynecol Oncol, 2004, 95:632-636.
  • 10Lissoni A, Cormio G, Perego P, et al. Conservative management of endometrial stromal sarcoma in young women. Int J Gynecol Cancer, 1997,7 : 364-367.

二级参考文献21

  • 1周应芳,吴北生,李辉,郑淑蓉.CA_(125)测定对子宫肌腺病的诊断价值[J].中华妇产科杂志,1996,31(10):590-593. 被引量:72
  • 2连利娟.卵巢癌单克隆抗体在诊断上的应用[J].中华妇产科杂志,1985,20(5):257-257.
  • 3孙建衡 连利娟.子宫颈浸润癌的放射治疗.林巧稚妇科肿瘤学(第1版)[M].北京:人民卫生出版社,1999.280-289.
  • 4孙建衡,林巧稚妇科肿瘤学,1999年,280页
  • 5Gerszten K,Gynecol Oncol,1998年,68卷,8页
  • 6Chi D S,Gynecol Oncol,1997年,65卷,493页
  • 7Hoffman W,Gynecol Obstet Invest,1996年,42卷,49页
  • 8Oclah K S,Eur J Cancer,1991年,27卷,1095页
  • 9Rose P G,Am J Obstet Gynecol,1987年,156卷,660页
  • 10Milojkovic M, Hrgovic Z, Hrgovic I, et al. Significance of CA 125 serum level in discrimination between benign and malignant masses in the pelvis. Arch Gynecol Obstet,2004 ,269 :176-180.

共引文献77

同被引文献48

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部